CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia.

In addition, we found that CoREST and LSD1 exhibit highly significant co-dependency with ZNF217 in genome-wide CRISPR KO screens across 1,139 cancer cell lines ( Figure S5 A and Supplementary Table 2 ).

also in 132,142 other papers